Patterns of Cancer Care Costs in a Country With Detailed Individual Data

OBJECTIVE: To determine health system expenditure on cancers by time since diagnosis using data for an entire country. METHODS: New Zealand cancer registry data was linked to hospitalization, pharmaceutical, outpatient, general practice, laboratory, and other datasets, with costs ascribed to each event occurring in 2006-2011. "Excess" cancer costs were estimated by subtracting "expected costs" for citizens without cancer from the "total cost" for cancer patients ($2011 inflation-adjusted). Gamma regressions were used to estimate costs per person-month. RESULTS: For first adult cancer diagnosed that the excess cost per person was between US$3400 and US$4300 in the first month postdiagnosis (varied by sex and age), fell to US$50-US$150 per month at 2 or more years postdiagnosis (excluding those within a year of death), but increased again if dying from their cancer (US$3800-US$8300 in the last month of life). Such patterns varied by cancer, for example, in the first month postdiagnosis for 65 year olds it varied 20-fold from US$800 for prostate to US$15,900 for brain cancer. Per diagnosed case, total excess costs varied from US$5000 (melanoma) to US$66,000 (bone and connective tissue) [Corrected]. Excess cancer costs made up 6.5% of total Vote:Health expenditure in 2010-2011, with colorectal (14.7%), breast (14.4%) being the top 2 contributors, and prostate, non-Hodgkin lymphoma, leukemia, and lung each contributing about 6%. CONCLUSIONS: Costs vary substantially by time since diagnosis and cancer type. The results and regression equations reported in this paper can be used in modeling requiring cancer costs by time since diagnosis and proximity to death

Breast cancer · Cancer · Cancer registry · Colorectal cancer · Health care · Lung cancer · Prostate cancer · Demography · Economic and Financial Impacts of Cancer · Global Cancer Incidence and Screening · Health Systems, Economic Evaluations, Quality of Life · Internal Medicine · Medicine · Oncology

• Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021

  Open Access•Louisa G Gordon, William Leung et al.•International Journal of…•2022

  Incluir item

• Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries

  Open Access•Ryan D Chow, Elizabeth H Bradley et al.•JAMA Health Forum•2022

  Incluir item

• The Economic Impact of Rectal Cancer

  Open Access•Anna Gigli, Silvia Francisci et al.•International Journal of…•2021

  Incluir item

• First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan

  Open Access•Tomone Watanabe, R Goto et al.•International Journal of…•2021

  Incluir item

• Disability-adjusted life years (Dalys) for 291 diseases and injuries in 21 regions, 1990–2010

  Open Access•Christopher J L Murray, Theo Vos et al.•The Lancet•2012

  Incluir item

• Projections of the Cost of Cancer Care in the United States

  Angela B Mariotto, K Robin Yabroff et al.•CancerSpectrum Knowledge…•2011

  Incluir item

• Advancing the Science of Health Care Costing

  Joseph Lipscomb, Paul G Barnett et al.•Medical Care•2009

  Incluir item

• Estimating Health Care Costs Related to Cancer Treatment From Seer-Medicare Data

  Martin L Brown, Gerald F Riley et al.•Medical Care•2002

  Incluir item

• Overview of Methods to Estimate the Medical Costs of Cancer

  William E Barlow•Medical Care•2009

  Incluir item